Lara Longpre Net Worth

Track Major Insider Updates On X/Twitter

Last Updated: 5 days, 6 hours ago

Lara Longpre has an estimated net worth of at least $10.1 million*, as of April 15, 2026. They own 104,369 shares of MIRM stock. They have sold 4,834 shares of MIRM stock since 2021, for an estimated $105,422.

Lara Longpre $MIRM SEC Form 4 Insider Trading

Lara Longpre has filed a total of 6 insider trades in $MIRM since 2021. Their most recent trade was a purchase of 965 shares, made on Sep 10, 2019. Their largest trade was a sale of 1,019 shares, made on Jan 08, 2024. We estimate that they now own 104,369 shares of $MIRM, worth an estimated $10.0 million.

Insider Trading at $MIRM

There have been a total of 135 insider trades reported at $MIRM since 2021, with 320,602 shares purchased and 1.3 million shares sold. The most active insider traders in $MIRM stock have been Jolanda Howe, Christopher Peetz, and Peter Radovich. The most recent trade was a sale of 2,000 shares reported by Saira Ramasastry (None), made on Apr 15, 2026.

History of Insider Stock Trades by Lara Longpre

Company Ticker	Purchase / Sale	Shares	Date	Disclosed (EST)
MIRM	Purchase	965	Sep 10, 2019	March 18, 2024, 5:40 p.m.
MIRM	Sale	1,003	Jan 09, 2023	March 18, 2024, 5:40 p.m.
MIRM	Sale	847	Feb 02, 2024	Feb. 5, 2024, 10:10 p.m.
MIRM	Sale	1,019	Jan 08, 2024	Jan. 9, 2024, 9:25 p.m.
MIRM	Sale	1,004	Jul 03, 2023	July 5, 2023, 7:37 p.m.
MIRM	Sale	961	Oct 01, 2021	Sept. 30, 2021, 8 p.m.

$MIRM Executives and Stock Owners with Insider Trades

Jolanda Howe, SVP, GLOBAL CONTROLLER
Christopher Peetz, CHIEF EXECUTIVE OFFICER
Peter Radovich, PRESIDENT AND COO
Eric Bjerkholt, CHIEF FINANCIAL OFFICER
Joanne Quan, CHIEF MEDICAL OFFICER
Lara Longpre, CHIEF DEVELOPMENT OFFICER
Ian Clements, Chief Financial Officer
Christopher Peetz, President and CEO
Pamela Vig, CHIEF SCIENTIFIC OFFICER
Jolanda Howe, SVP, Global Controller
Lara Longpre, Chief Development Officer
Peter Radovich, Chief Operating Officer
Eric Bjerkholt, Chief Financial Officer
Edwin Jonathan Tucker, Chief Medical Officer
Christopher Peetz, PRESIDENT AND CEO
Pamela Vig, Chief Scientific Officer
Pamela Vig, HEAD OF RESEARCH & DEVELOPMENT
Pamela Vig, Head of Research & Development
Peter Radovich, CHIEF OPERATING OFFICER

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.